Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations

NCT ID: NCT00522600

Last Updated: 2009-07-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-02-28

Study Completion Date

2007-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be used to evaluate how patients put eye drops in their eyes and any problems that may arise from this activity. The information gathered will help identify common problems patients are having with putting in their eye medications. Then doctors can be better informed about the issues and provide better advice to their patients to overcome these problems.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Approximately 100 patients will take part in a one time procedure and survey as part of this project. After appropriate consent patients are asked to complete a short 2 page survey about themselves and their eye drops. Then a video recording will be made of the patient instilling eye drops in their habitual manner. The eye drops used will be sterile saline placed in either Travatan-like or Systane bottles to simulate the corresponding prescribed medication. The videos will be graded for instillation technique and combined with scoring of survey answers.

Patients will be asked to instill the drops to their left eye with their dominant hand as we expect this to be most difficult. Patients with severe (\>20/200) vision loss will instill drops into their better seeing eye.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma Dry Eye Syndrome Conjunctivitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Currently using topical glaucoma medications
Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alcon Research

INDUSTRY

Sponsor Role collaborator

Robin, Alan L., M.D.

INDIV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Glaucoma Specialists

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jennifer L Stone, OD

Role: PRINCIPAL_INVESTIGATOR

Alan L Robin MD PA

Alan L Robin, MD

Role: STUDY_DIRECTOR

Alan L Robin MD PA

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

ALan L Robin MD PA

Baltimore, Maryland, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Stone JL, Robin AL, Novack GD, Covert DW, Cagle GD. An objective evaluation of eyedrop instillation in patients with glaucoma. Arch Ophthalmol. 2009 Jun;127(6):732-6. doi: 10.1001/archophthalmol.2009.96.

Reference Type DERIVED
PMID: 19506189 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.glaucomaexpert.com

official practice homepage

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SI0717

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.